GeneCentric Therapeutics Announces Presentations at Upcoming American Society of Clinical Oncology (ASCO) Annual Meeting

June 2, 2021 8:00 AM

Ongoing Collaboration with Basilea Pharmaceutica International Ltd and their Lisavanbulin Clinical Program in Glioblastoma Will Be Highlighted at ASCO DURHAM, NC / ACCESSWIRE / June 2, 2021 / GeneCentric Therapeutics, a company making precision medicine more precise, today announced upcoming data presentations at the American Society of Clinical Oncology (ASCO) annual meeting, being held virtually June 4th through 8th. The presentations will...

Read more

Hillstream BioPharma Announces Abstract at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Highlighting HSB-1216’s Effect in Triple Negative Breast Cancer (TNBC)

June 2, 2021 8:00 AM

HSB-1216 and a Novel Anthracycline, Pirarubicin, Combined and Targeted Using Quatramer Shows Synergistic Effect in TNBC BRIDGEWATER, NJ / ACCESSWIRE / June 2, 2021 / Hillstream BioPharma, Inc. ("Hillstream") today announced that an abstract highlighting the progress of HSB-1216 pipeline candidate is being presented as an online publication only at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting taking place...

Read more

HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug

June 2, 2021 8:00 AM

The Company will seek Orphan Drug Designation to significantly reduce time to market VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce the completion of the previously announced...

Read more

Health Canada Accepts New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting

June 2, 2021 7:30 AM

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 28, 2021 to its short form base shelf prospectus dated April 1, 2020 The Company approaches a significant milestone advancing from a pre-revenue biotech to in revenue OTTAWA, ON / ACCESSWIRE / June 2, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF)...

Read more

Apollo Endosurgery to Present at June Investor Conferences

June 1, 2021 12:00 PM

AUSTIN, TX / ACCESSWWIRE / June 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that management will participate in two investor conference events during the month of June 2021. Conferences Apollo Endosurgery management will participate include: Wednesday, June 2, 2021 18th Annual Craig-Hallum...

Read more

Applied UV’s Airocide(TM) System Installed in Uruguayan School System

June 1, 2021 8:30 AM

60 Airocide® Units now operating in Colegio Santa Elena Installation is expected to be first of many as international expansion strategy accelerates Installation in school system follows recently awarded $3.5 million minimum first year purchase commitment to Applied UV from South Africa distributor MOUNT VERNON, NY / ACCESSWIRE / June 1, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"),...

Read more

Thermic Science Proudly Receives OTC Markets Registration Confirmation, Makes Payment of Initial Exchange Fees to Begin Uploading its Financials and Reporting Requirements to Bring the Company Current and in Compliance with the Amended Rule 15c2-11

June 1, 2021 7:05 AM

NASHVILLE, TN / ACCESSWIRE / June 1, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka Endocan Corporation. (WKN:A1W61J) (ISIN:US29271J1097) (OTC PINK:ENDO), is proud to announce it has officially received OTC Markets registration confirmations, completing its new OTC Markets registration ready to upload all newly updated State of Nevada registered corporate information. Thermic Science...

Read more

World Class Provides Pineapple Express Delivery Revenue Update

June 1, 2021 3:30 AM

Pineapple Express Delivery's revenue total $2.77M January - April 2021 VANCOUVER, BC / ACCESSWIRE / June 1, 2021 / World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) ("Company" or "World-Class"), is pleased to provide an update on Pineapple Express Delivery Inc. ("Pineapple Express Delivery" or "PED"), a company in which World-Class has a controlling interest. PED is a leading logistics...

Read more

Experion Reports on AGM Results

May 31, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / May 31, 2021 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce the results of its annual general and special meeting of the shareholders held by way of live virtual webcast on May 26, 2021 (the "Meeting"). All of the matters put forward before shareholders for consideration and approval as set out in Experion's...

Read more

Edesa Biotech to Join Panel Discussion at Industry Event

May 28, 2021 8:00 AM

TORONTO, ON / ACCESSWIRE / May 28, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, announced today that Dr. Par Nijhawan, Chief Executive Officer, is scheduled to participate in a virtual event organized by the Ontario Bioscience Innovation Organization. As part of a panel of health science and investment professionals, Dr. Nijhawan is expected to discuss publicly available information regarding Edesa and...

Read more

Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19

May 27, 2021 1:15 AM

EMPATHY global multi-center Phase 2 - 3 study, recruiting patients with COVID-19 infection, aiming to prevent worsening symptoms and hospitalization The study plans to enroll 2100 patients, with 400 patients to be enrolled into Phase 2, followed by 1700 patients in Phase 3 Novartis has been granted an option from Molecular Partners to in-license global rights of ensovibep and MP0423 - DARPin® antiviral therapeutic...

Read more

Enzolytics Announces the Discovery of Conserved, Immutable Target Sites on HTLV-1 and Plans To Commence Production of Monoclonal Antibodies Targeting These Sites

May 26, 2021 7:30 AM

COLLEGE STATION, TX / ACCESSWIRE / May 26, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) (the "Company") today announced it has identified conserved, expectedly immutable sites on the HTLV-1 virus against which it will produce targeted anti-HTLV-1 monoclonal antibodies (mAbs). There are no effective vaccines against HTLV-1 and no antiviral drugs available for treating infections caused by the virus. Utilizing the Company's proprietary...

Read more

ASTR Institute Announces at Home Pain Relief Breakthrough

May 25, 2021 10:00 AM

BOISE, ID / ACCESSWIRE / May 25, 2021 / The ASTR Institute is pleased to announce their Advanced Soft Tissue Release pain treatment program, once only available in a clinical setting, is now available for home use. ASTR is a treatment approach developed by Dr. Joseph Jacobs that treats pain at its source. This program takes less than 5 minutes a day, with easy to use medical tools and a holistic approach to healing. ASTR was created by a doctor...

Read more

Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech

May 25, 2021 8:00 AM

Pieris will receive $20 million as an upfront payment and is eligible to receive more than $1.4 billion in additional potential milestone payments plus royalties for commercialized programs Collaboration includes initial programs in respiratory disease and ophthalmology, with opportunity to nominate additional programs BOSTON, MA / ACCESSWIRE / May 25, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology...

Read more

Thermic Science Gives Financial Update and Guidance as it Announces Financials for Filings Have Been Completed Internally in Compliance with Rule 15c2-11 and OTC Market Reporting Changes

May 24, 2021 9:45 AM

NASHVILLE, TN / ACCESSWIRE / May 24, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J) (ISIN:US29271J1097) (OTC PINK:ENDO), is pleased to announce that the company's financials have been completed internally and are expected to be filed in the next 30 days. Furthermore, it is through these filings the company is compliant with the OTC rule 15c2-11 and OTC...

Read more

Wuhan General Group Appoints Robert "Black Tiger" Simbowe as Director of Health and Fitness

May 24, 2021 9:00 AM

CAPE TOWN, SA / ACCESSWIRE / May 24, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update: The company is pleased to announce the appointment of Robert Simbowe as Director of Health and Fitness. Robert is a professional MMA fighter with the...

Read more

Dyadic to Present at Upcoming Events

May 24, 2021 8:30 AM

JUPITER, FL / ACCESSWIRE / May 24, 2021 / Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ:DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company will participate in the...

Read more

Alkame's Build Out of New Production Facility Nearing Operational Status

May 24, 2021 8:00 AM

LAS VEGAS, NV / ACCESSWIRE / May 24, 2021 / Alkame Holdings, Inc. (OTC PINK:ALKM), a diversified holding company, is pleased to announce that the buildout of its wholly-owned subsidiary West Coast Co-Packer, Inc.'s new production facility is nearing operational status. The new West Coast Copacker food and beverage manufacturing facility located in Salem Oregon will allow for business growth with additional room for further continued...

Read more

Apollo Endosurgery's Innovative OverStitch(TM) Endoscopic Suturing System Highlighted During Digestive Disease Week 2021

May 24, 2021 7:00 AM

AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced highlights from Digestive Disease Week (DDW) 2021 which was held May 21-23. During the 3-day virtual event, there were more than 30 different presentations featuring the use of the OverStitch™ Endoscopic Suturing System in a...

Read more

Wuhan General Group Appoints Michael Sachar CEO of M2Bio Sciences Food & Beverage

May 20, 2021 9:05 AM

CAPE TOWN, SA / ACCESSWIRE / May 20, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update: The company is pleased to announce the appointment of Michael Sachar as CEO of M2Bio Sciences Food & Beverage. Michael brings with him 17 years of extraordinary...

Read more